HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

496.657

-6.741-1.34%

Number of Gainers:8

Number of Losers:21

Number of Flat:4

PE:- -

High:505.901

Open:503.516

Low:493.245

Close:503.398

Volume:25.36M

Turnover:967.96M

Market Cap:317.26B

Float Cap:280.75B

Loading ...

Finally Tasting the Gains in the Healthcare Sector Today!

HK Stock Market Highlights: Haizhi Tech's H1 FY2026 Revenue Jumps 70.4% as Agent Business Takes Off

Novartis Secures New Chinese Approval for Key Radiopharmaceutical Therapy

Zai Lab's Net Loss Widens 14% in H1, Revenue Drops 6%

MT Newswires Live

AKESO's Novel Dual Antibody Achieves Positive Phase III Results in Biliary Tract Cancer, Marking First Solid Tumor Expansion Beyond Lung Cancer

Akeso - Ivonescimab Plus Chemo Meets Primary Endpoint with Significant Os Benefit in 1L BTC

THOMSON REUTERS

Akeso - Harmoni-Gi1 First Phase Iii Study to Show Significant Os Benefit Versus Global Standard in Biliary Tract Cancer

THOMSON REUTERS

Ivonescimab Plus Chemotherapy Demonstrates Significant Overall Survival Benefit Versus Durvalumab Plus Chemotherapy in First-Line Biliary Tract Cancer: Harmoni-Gi1 Meets Primary Endpoint

THOMSON REUTERS

Akeso - Study Meets Key Secondary Endpoints of Progression-Free Survival and Objective Response Rate

THOMSON REUTERS

Electromed's Q4 Revenue Slightly Beats Estimates on Homecare Strength

Is HBM Holdings (SEHK:2142) Fully Valued After Its HBM7004 IND Approval?

Simply Wall St.

China's Weigao H1 Profit Falls 23% as Price Drops, Competition Hit Margins

C-Mer Eye Care's H1 Revenue Rises, Net Profit Flat

China's Neptunus Interlong H1 Revenue Falls

Sweden's SyntheticMR Q2 Sales Rise, Loss Narrows on cNeuro Strength, India Growth

China's Hospital Corporation Half-Year Profit Drops on Service Revenue Decline

Canada's LSL Pharma Q2 Revenue Surges on Acquisition Boost, Eye-Drop Launches

Redefining Roles: Commercial Health Insurance Enters a New Era of Partnership in China's Next Five-Year Plan

Market Sentiment Stabilizes as Sanctions Prove Largely Symbolic; Tech Benchmarks Surge on Potential Dovish Fed Signals

ETF Market Daily: Healthcare Sector Shows Solid Valuations While Innovative Drug Subsegments See Dense Catalysts, Spotlight on Hang Seng Biotech ETF and STAR Innovative Drug ETF

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/BK1574/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":496.65738,"timestamp":1788229031222,"preClose":503.39795,"halted":0,"volume":25357402,"delay":0,"changeRate":-0.01339,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-6.74057,"latestTime":"09-01 10:17:11","open":503.51608,"high":505.9005,"low":493.2451,"amount":967958145,"amplitude":0.02514,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1788235200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1788226200000,1788235200000],[1788238800000,1788249600000]],"pbRate":3.790203,"peRate":127.340212,"turnoverRate":0.000965,"increases":8,"decrements":21,"flats":3,"marketCap":317263350128,"floatMarketCap":280745431208},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":505.9005,"amplitude":0.02514,"preClose":503.39795,"low":493.2451,"pbRate":"3.790203","latestPrice":496.65738,"volume":25357402,"delay":0,"open":503.51608,"prevYearClose":556.26263,"prevWeekClose":523.873,"prevMonthClose":503.398,"prevQuarterClose":453.519,"fiveDayClose":512.773,"twentyDayClose":475.248,"sixtyDayClose":459.637,"secType":"PLATE","market":"HK","turnoverRate":0.000965,"peRate":127.340212,"marketCap":317263350128,"floatMarketCap":280745431208,"timestamp":1788229031222,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":8,"down":21,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1192662003","title":"Finally Tasting the Gains in the Healthcare Sector Today!","url":"https://stock-news.laohu8.com/highlight/detail?id=1192662003","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192662003?lang=en_us&edition=fundamental","pubTime":"2026-08-26 09:21","pubTimestamp":1787707280,"startTime":"0","endTime":"0","summary":"After Bessent detailed the \"economic war\" tactics against Iran, oil prices took a sharp dive. This isn't because the conflict has reached its conclusion; rather, the US Treasury is expanding the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1161","159938","BK1574","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115078027","title":"HK Stock Market Highlights: Haizhi Tech's H1 FY2026 Revenue Jumps 70.4% as Agent Business Takes Off","url":"https://stock-news.laohu8.com/highlight/detail?id=1115078027","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115078027?lang=en_us&edition=fundamental","pubTime":"2026-08-26 09:17","pubTimestamp":1787707028,"startTime":"0","endTime":"0","summary":"Key corporate developments this week: GenFleet Therapeutics-B (02595) has initiated a Phase II study evaluating GFH375, an oral KRAS G12D inhibitor, as a first-line treatment for non-small cell lung...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BPRC5H50.USD","00660","BK4585","BK1589","LU1961090484.USD","LU0417516902.SGD","BK1586","LU2488822045.USD","LU0348827113.USD","KCAI","BK4588","BK1574","00354","IE00B543WZ88.USD","VXUS","BK1526","LU0417516571.SGD","LU0561508036.HKD","IE00B5MMRT66.SGD","LU2778985437.USD","LU0348825331.USD","LU2476274308.USD","LU0417516738.SGD","BK1518","LU1794554557.SGD","BK1161","BK1237","LU1720050803.USD","02595","LU0348783233.USD","LU2399975544.HKD","LU0634319403.HKD","LU2476274720.SGD","LU0348766576.USD","LU0348735423.USD","LU0540923850.HKD","09926","LU0348784397.USD","BK1155","KURE","LU0348767384.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129968594","title":"Novartis Secures New Chinese Approval for Key Radiopharmaceutical Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=1129968594","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129968594?lang=en_us&edition=fundamental","pubTime":"2026-08-26 08:50","pubTimestamp":1787705420,"startTime":"0","endTime":"0","summary":"On August 25, Novartis AG (NVS.US) announced that its radiopharmaceutical lutetium [177Lu] vipivotide tetraxetan (Chinese brand name: Paiweitou) received a new indication approval in China. The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVS","IE00BJT1NW94.SGD","LU0070302665.USD","BK4532","BK1574","IE00B4R5TH58.HKD","01477","IE0002141913.USD","IE00B2B36J28.USD","LU0211331839.USD","IE00BFTCPJ56.SGD","LU0320765489.SGD","IE00BJJMRZ35.SGD","MEDX","BK4578","IE0009355771.USD","LU0208291251.USD","BK1191","BK4588","PPH","BK4585","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662639247","title":"Zai Lab's Net Loss Widens 14% in H1, Revenue Drops 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662639247","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662639247?lang=en_us&edition=fundamental","pubTime":"2026-08-26 08:23","pubTimestamp":1787703832,"startTime":"0","endTime":"0","summary":"Zai Lab  incurred $101.8 million in net loss in the first half of the year, wider by 14% from $89.2 million a year earlier, according to a Wednesday filing to the Hong Kong stock exchange.Loss per share came in at $0.09 compared with $0.08 a year earlier, the biopharmaceutical company said.Net product revenue during the period fell 6% to $201.3 million from $214.7 million a year prior.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1588","BK1574","LU2488822045.USD","09688","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197055899","title":"AKESO's Novel Dual Antibody Achieves Positive Phase III Results in Biliary Tract Cancer, Marking First Solid Tumor Expansion Beyond Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1197055899","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197055899?lang=en_us&edition=fundamental","pubTime":"2026-08-26 07:42","pubTimestamp":1787701336,"startTime":"0","endTime":"0","summary":"AKESO (09926) has announced that its independently developed, first-in-class bispecific antibody, 依达方® (ivonescimab, PD-1/VEGF), combined with chemotherapy, demonstrated a statistically significant...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417516738.SGD","LU0634319403.HKD","LU0348767384.USD","LU0417516571.SGD","LU0348735423.USD","KURE","LU0348783233.USD","LU2778985437.USD","LU1961090484.USD","LU2476274720.SGD","LU2488822045.USD","LU0540923850.HKD","LU1794554557.SGD","09926","LU2399975544.HKD","LU0348766576.USD","LU0417516902.SGD","III","IE00B5MMRT66.SGD","LU0561508036.HKD","LU1720050803.USD","LU0348827113.USD","BK1574","LU0348784397.USD","IE00BPRC5H50.USD","IE00B543WZ88.USD","BK1161","LU0348825331.USD","LU2476274308.USD","BK4134"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662685897","title":"Akeso - Ivonescimab Plus Chemo Meets Primary Endpoint with Significant Os Benefit in 1L BTC","url":"https://stock-news.laohu8.com/highlight/detail?id=2662685897","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662685897?lang=en_us&edition=fundamental","pubTime":"2026-08-26 07:01","pubTimestamp":1787698884,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nFWN44M0TW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KURE","BK1574","LU1961090484.USD","IE00BPRC5H50.USD","LU0634319403.HKD","LU2476274308.USD","LU0348766576.USD","BK1161","IE00B5MMRT66.SGD","LU0348825331.USD","LU2399975544.HKD","LU1720050803.USD","LU0348783233.USD","LU0561508036.HKD","LU1794554557.SGD","LU0417516571.SGD","LU2778985437.USD","LU0417516738.SGD","LU0417516902.SGD","LU2476274720.SGD","LU0348827113.USD","09926","LU2488822045.USD","LU0348735423.USD","LU0348767384.USD","LU0540923850.HKD","IE00B543WZ88.USD","LU0348784397.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662752407","title":"Akeso - Harmoni-Gi1 First Phase Iii Study to Show Significant Os Benefit Versus Global Standard in Biliary Tract Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662752407","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662752407?lang=en_us&edition=fundamental","pubTime":"2026-08-26 05:00","pubTimestamp":1787691600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nTUA5XV27P:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1794554557.SGD","LU1720050803.USD","LU0348783233.USD","LU1961090484.USD","KURE","LU0348766576.USD","LU0348784397.USD","LU0348825331.USD","LU0417516738.SGD","BK1161","LU2476274308.USD","IE00BPRC5H50.USD","LU0417516902.SGD","LU0540923850.HKD","LU2778985437.USD","09926","LU0348827113.USD","IE00B543WZ88.USD","LU2476274720.SGD","LU0417516571.SGD","BK1574","LU2488822045.USD","LU0561508036.HKD","LU2399975544.HKD","LU0348735423.USD","LU0348767384.USD","IE00B5MMRT66.SGD","LU0634319403.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662524007","title":"Ivonescimab Plus Chemotherapy Demonstrates Significant Overall Survival Benefit Versus Durvalumab Plus Chemotherapy in First-Line Biliary Tract Cancer: Harmoni-Gi1 Meets Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2662524007","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662524007?lang=en_us&edition=fundamental","pubTime":"2026-08-26 05:00","pubTimestamp":1787691600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nTUA5XV27P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B5MMRT66.SGD","LU0634319403.HKD","LU2476274720.SGD","LU0348825331.USD","LU0561508036.HKD","LU0348766576.USD","LU0348784397.USD","LU0348783233.USD","LU0348827113.USD","LU0417516738.SGD","IE00B543WZ88.USD","LU0348767384.USD","LU2476274308.USD","LU0417516902.SGD","LU1961090484.USD","09926","IE00BPRC5H50.USD","LU1720050803.USD","LU2399975544.HKD","LU0417516571.SGD","LU2488822045.USD","BK1161","LU0540923850.HKD","LU2778985437.USD","KURE","LU1794554557.SGD","BK1574","LU0348735423.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662401752","title":"Akeso - Study Meets Key Secondary Endpoints of Progression-Free Survival and Objective Response Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2662401752","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662401752?lang=en_us&edition=fundamental","pubTime":"2026-08-26 05:00","pubTimestamp":1787691600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nTUA5XV27P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0540923850.HKD","LU1720050803.USD","LU2488822045.USD","LU0417516571.SGD","KURE","BK1161","LU0634319403.HKD","LU0417516738.SGD","LU1794554557.SGD","LU0348767384.USD","09926","LU0348825331.USD","LU0348783233.USD","LU2399975544.HKD","IE00BPRC5H50.USD","LU0348735423.USD","LU0348827113.USD","IE00B543WZ88.USD","LU2778985437.USD","LU0348784397.USD","IE00B5MMRT66.SGD","LU0348766576.USD","LU2476274308.USD","LU0561508036.HKD","LU1961090484.USD","BK1574","LU0417516902.SGD","LU2476274720.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662278754","title":"Electromed's Q4 Revenue Slightly Beats Estimates on Homecare Strength","url":"https://stock-news.laohu8.com/highlight/detail?id=2662278754","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662278754?lang=en_us&edition=fundamental","pubTime":"2026-08-26 04:15","pubTimestamp":1787688928,"startTime":"0","endTime":"0","summary":"Electromed's Q4 revenue slightly beats estimates on homecare strengthOverviewUS airway clearance device maker's fiscal Q4 revenue rose, slightly beating analyst expectationsFiscal Q4 net income rose 5","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL1N44M0WF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELMD","BK1100","BK4082","BK1574","BK1583","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662349759","title":"Is HBM Holdings (SEHK:2142) Fully Valued After Its HBM7004 IND Approval?","url":"https://stock-news.laohu8.com/highlight/detail?id=2662349759","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662349759?lang=en_us&edition=fundamental","pubTime":"2026-08-26 00:18","pubTimestamp":1787674691,"startTime":"0","endTime":"0","summary":"HBM Holdings (SEHK:2142) is back in focus after Harbour BioMed received approval from China’s National Medical Products Administration for an Investigational New Drug application linked to HBM7004, a bispecific antibody targeting advanced solid tumors.\nSee our latest analysis for HBM Holdings.\nThe HBM7004 IND approval arrives as HBM Holdings trades at HK$16.54, with a 30-day share price return of 32.21% and a 90-day share price return of 40.77%, while the 3-year total shareholder return is...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2142/hbm-holdings-shares/news/is-hbm-holdings-sehk2142-fully-valued-after-its-hbm7004-ind","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2142/hbm-holdings-shares/news/is-hbm-holdings-sehk2142-fully-valued-after-its-hbm7004-ind","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HBMX","BK4168","HBM","BK4588","DRAM","DRMY","MULL","RAMZ","MUYY","DRMP","02142","DISK","MUG","MUD","RAM","COPP","DRAL","MUZ","MUU","MIC","BK1574","DCF","BK1583","BK1161","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662771732","title":"China's Weigao H1 Profit Falls 23% as Price Drops, Competition Hit Margins","url":"https://stock-news.laohu8.com/highlight/detail?id=2662771732","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662771732?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:55","pubTimestamp":1787662510,"startTime":"0","endTime":"0","summary":"China's Weigao H1 profit falls 23% as price drops, competition hit marginsOverviewChina medical device maker's H1 revenue rose 3.1% yr/yr, net profit fell 23.2%Gross margin dropped 3.4 percentage poin","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL1N44M0D9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09996","BK1574","LU0173614495.USD","BK1583","BK1100","LU0287142896.SGD","01066","BK1222","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662873220","title":"C-Mer Eye Care's H1 Revenue Rises, Net Profit Flat","url":"https://stock-news.laohu8.com/highlight/detail?id=2662873220","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662873220?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:52","pubTimestamp":1787662323,"startTime":"0","endTime":"0","summary":"C-Mer Eye Care's H1 revenue rises, net profit flatOverviewEye care provider's revenue rose 8.5% yr/yr for six months ended JuneNet profit attributable to equity holders increased 0.2% yr/yrAdjusted pr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL1N44M0D2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03309","09996","BK1100","BK1209","BK1583","BK1219","BK1574","BK1516"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662644732","title":"China's Neptunus Interlong H1 Revenue Falls","url":"https://stock-news.laohu8.com/highlight/detail?id=2662644732","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662644732?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:41","pubTimestamp":1787661677,"startTime":"0","endTime":"0","summary":"China's Neptunus Interlong H1 revenue fallsOverviewChina pharma and medical device firm's H1 revenue fell year-over-yearNet income attributable to owners declined for the half-year periodNo interim di","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL1N44M0C6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","09996","BK0239","BK1161","688428","01167","BK1583","BK1100","08329","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662399732","title":"Sweden's SyntheticMR Q2 Sales Rise, Loss Narrows on cNeuro Strength, India Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2662399732","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662399732?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:36","pubTimestamp":1787661380,"startTime":"0","endTime":"0","summary":"Sweden's SyntheticMR Q2 sales rise, loss narrows on cNeuro strength, India growthOverviewSweden medical imaging firm's Q2 sales rose 13% yr/yrOperating loss for Q2 narrowed to -6.5 mln SEK from -8.6 m","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL1N44M0CW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","09996","BK1583","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662573287","title":"China's Hospital Corporation Half-Year Profit Drops on Service Revenue Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2662573287","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662573287?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:33","pubTimestamp":1787661209,"startTime":"0","endTime":"0","summary":"China's Hospital Corporation half-year profit drops on service revenue declineOverviewChina hospital operator's half-year revenue declined slightly from prior yearNet income attributable to shareholde","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL1N44M0C4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03869","09996","BK1574","BK1583","BK1100","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662042734","title":"Canada's LSL Pharma Q2 Revenue Surges on Acquisition Boost, Eye-Drop Launches","url":"https://stock-news.laohu8.com/highlight/detail?id=2662042734","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662042734?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:30","pubTimestamp":1787661003,"startTime":"0","endTime":"0","summary":"Canada's LSL Pharma Q2 revenue surges on acquisition boost, eye-drop launchesOverviewCanada pharmaceutical maker's fiscal Q2 revenue more than doubled yr/yr to record highCompany posted wider net loss","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL1N44M0C3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688428","BK1574","BK0239","01167","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160672856","title":"Redefining Roles: Commercial Health Insurance Enters a New Era of Partnership in China's Next Five-Year Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1160672856","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160672856?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:10","pubTimestamp":1787659849,"startTime":"0","endTime":"0","summary":"A pivotal policy document released by the National Healthcare Security Administration in August set the stage for a fundamental shift in China's medical insurance landscape.For the first time, the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","IBBQ","06978","MEDX","LNGR","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102179577","title":"Market Sentiment Stabilizes as Sanctions Prove Largely Symbolic; Tech Benchmarks Surge on Potential Dovish Fed Signals","url":"https://stock-news.laohu8.com/highlight/detail?id=1102179577","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102179577?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:03","pubTimestamp":1787659392,"startTime":"0","endTime":"0","summary":"Market dynamics took a surprising turn today as the harsh \"devastating\" sanctions threatened by the U.S. yesterday turned out to be more bark than bite. A-shares closed higher while Hong Kong stocks...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2244417387.USD","LU2360107168.USD","BK4612","06821","SG9999015978.USD","SHOC","IE00BKVL7J92.USD","SG9999017495.SGD","LU2236285917.USD","NVD2.UK","LU1712237335.SGD","LU2097344357.USD","LU0128525929.USD","LU2250418816.HKD","LU2746668461.USD","LU0109392836.USD","LU0348814723.USD","LU0786609619.USD","LU1794554557.SGD","LU1868837300.USD","HK0000304805.HKD","LU0819121731.USD","LU1934455194.USD","LU0173614495.USD","LU2452424414.USD","LU1188198961.HKD","LU0314109678.HKD","LU1551013342.USD","BABA","LU1868837136.USD","LU1815333072.USD","LU2087621335.USD","LU0516422952.EUR","LU0345768740.USD","LU2746668974.SGD","LU0061474705.USD","HK0000320264.USD","LU0229945570.USD","LU1720051017.SGD","IE00B4YYXB79.USD","LU2237957902.USD","SG9999000418.SGD","LU0267386448.USD","LU0417517546.SGD","LU1400636491.USD","LU0225283273.USD","LU1496350502.SGD","LU0154236417.USD","ONLN","LU0128525689.USD","LU0265550359.USD","LU2039709279.SGD","IE0004445239.USD","FAI","AGOX","LU0067412154.USD","LU2125909759.SGD","LU0488056044.USD","THMR","SGXZ23171101.USD","LU0708995583.HKD","LU0052750758.USD","LU2471134523.USD","BK4592","01548","LU1267930490.SGD","LU2491050071.SGD","LU2458330243.SGD","BK4220","LU1066051811.HKD","LU1202635105.USD","IE00B1BXHZ80.USD","LU1066053197.SGD","LU0444973449.USD","LU0942090050.USD","LU0353189680.USD","IE00BJLML261.HKD","LU0651947912.USD","LU2237443465.HKD","LU1861127337.USD","LU2125909593.SGD","3NVD.UK","LU2592432038.USD","LU0061475181.USD","LU2065171311.SGD","SG9999002232.USD","SG9999018865.SGD","TRFK","BK1161","LU1969619763.USD","LU1923623000.USD","IE00B0JY6N72.USD","LU1115378108.SGD","LU1852331112.SGD","LU2133065610.SGD","BABX","LU0328353924.USD","IE00BZ199S13.USD","LU1880398471.USD","LU0630378429.USD","LU1069344957.HKD","BK4503","LU0157215616.USD","LU1791710582.SGD","LU0082616367.USD","89888","LU2237443622.USD","XLK","METV","LU0444971666.USD","LU1548497426.USD","LU0323591593.USD","LU0316494557.USD","LU2083900584.USD","BK1170","BK4598","IE00B775SV38.USD","BK1521","BK1609","LU2187417386.USD","LU2361044865.SGD","NVDD","IE000KEQY171.SGD","LU0342679015.USD","LU2092937148.SGD","LU1688375341.USD","SGXZ81514606.USD","LU0056508442.USD","IE0003U64NQ7.SGD","LU1515016050.SGD","SG9999002463.SGD","BK4587","LU2242650005.HKD","SG9999004220.SGD","LU0456827905.SGD","BK1618","LU1839511570.USD","BABW","HK0000306685.HKD","LU1003077747.HKD","LU2351347302.SGD","LU2896262040.SGD","IE00BK4W5M84.HKD","LU0787776722.HKD","LU2168564065.EUR","LU2028103732.USD","BK4526","LU1023057109.AUD","09988","LU0320764599.SGD","BK1506","IE00B19Z9505.USD","WISE","LU2290526834.HKD","NVII","LU0158827948.USD","LU2476274308.USD","SG9999014575.USD","LU1988902786.USD","IE00BMPRXN33.USD","BK4534","LU2552382215.SGD","NULC","IE00BQXX3C00.GBP","IE00B775H168.HKD","LU1048596156.SGD","BK1516","BK4607","LU0327786744.USD","SG9999002224.SGD","BK4585","LU0494093205.USD","LU2125154778.USD","LU1935042991.SGD","LU2461242641.AUD","IE00B1XK9C88.USD","LU0831093199.SGD","BK4543","LU0079474960.USD","LU0072913022.USD","NVDQ","VGT","LU0287142896.SGD","LU0726765562.USD","SG9999015952.SGD","LU0882574139.USD","LU2506951792.HKD","BK4505","AIFD","01057","IE00BK4W5L77.USD","SPTE","BK1589","BK4529","NVDO","LU2756315664.SGD","IE00B3SWFQ91.USD","LU0070217475.USD","LU2264538146.SGD","SG9999014559.SGD","LU0164865239.USD","IE000Q6AESB8.SGD","LU1831875114.USD","LU2471134952.CNY","2NVD.UK","LU2778985437.USD","LU0345770308.USD","SG9999006597.SGD","LU1814569148.SGD","LU1084165304.USD","SGXZ31699556.SGD","LU3063872942.SGD","LU2265009873.SGD","LU1571399168.USD","LU2488822045.USD","LU1144417596.USD","BK4581","LU1267930730.SGD","LU0964807845.USD","LU1674673691.USD","BK1132","BK4575","KBDCY","LU2023250504.SGD","IE00B3M56506.USD","LU2413666426.HKD","LU1282649810.SGD","LU0210533765.USD","LU0051755006.USD","LU1366333091.USD","BIDU","LU1868836914.USD","LU2357125470.USD","601869","LU0943347566.SGD","LU2125154935.USD","LU0572944931.SGD","IE00BDRTCR15.USD","LU2750360997.AUD","CMAG","LU0077335932.USD","BK4533","AIPI","LU1769817096.USD","LU2272731600.USD","LU1051769294.HKD","LU2347655073.USD","ANV","LU1119994496.HKD","LU0215105999.USD","NVDU","LU0289960550.SGD","LU0107464264.USD","BK4550","LU2191332357.HKD","00148","LU2505996509.AUD","NVDS.UK","CNEQ","LU2637965513.SGD","LU0463099449.HKD","LU1235294995.USD","LU2999663052.SGD","IE00BKPKM429.USD","LU1116320737.USD","LU0096364046.USD","SNVDAmain","LU0061474960.USD","LU2237443549.SGD","IETC","LU0323240290.USD","LU1066051498.USD","LU2430703178.SGD","LU0472753341.HKD","SGXZ51526630.SGD","LU2473716301.USD","LU0708994859.HKD","IXN","LU2213496289.HKD","LU0072462343.USD","LU1992135472.HKD","LU1813983027.USD","LU0228367735.SGD","LU0238689110.USD","LU2471134879.HKD","BK4527","LU0052756011.USD","HK0000320223.HKD","LU0918141887.USD","LU2491050154.USD","LU0289739343.SGD","CHPX","IE00BF5LJ272.USD","LU0347712357.USD","LU0163747925.USD","LU1328615791.USD","LU2054465674.USD","LU0227179875.USD","LU1992135399.USD","LU0640798160.USD","LU1989764664.SGD","LU0315179316.USD","LU0395794307.EUR","LU1069347547.HKD","LU1914381329.SGD","NVD3.UK","LU0197773160.USD","LU0820562030.AUD","LU1261432733.SGD","BK1615","LU0528227936.USD","LU0276348264.USD","LU1035773651.USD","LU2430703251.USD","NVYY","LU1037948897.HKD","LU0244354667.USD","01952","LU0011850046.USD","LU2322448957.HKD","LU0683600562.USD","IE00BYXW3230.USD","LU0106959298.USD","LU1815336760.USD","BK4608","LU1989772923.USD","BK1576","SMH","LU1721428933.USD","LU0868494617.USD","LU0256863811.USD","LU0965508806.USD","SG9999014542.SGD","LU0823426480.USD","LU1934455277.USD","ESUM","LU1791710400.SGD","LU1979441026.SGD","LU2420271590.USD","LU2279689827.SGD","LU1951200564.SGD","LU0006306889.USD","LU0251143458.SGD","BK1523","IE00BN29S564.USD","LU1861215975.USD","LU1989764748.USD","BK1574","02269","LU1400636657.SGD","LU0203202063.USD","LU2462157665.USD","LU0081259029.USD","BK1509","LU1917777945.USD","LU0823421333.USD","USD","BK1095","LU2168563687.JPY","GB00BDT5M118.USD","LU0651946864.USD","LU1868836591.USD","BK4614","LU0265550946.USD","BK4588","LU1211504680.USD","LU2381873111.SGD","LU3102509885.SGD","IE00B4JS1V06.HKD","BK1596","IE000YTNTUN2.SGD","FPA","LU0823434583.USD","LU2750360641.GBP","SG9999001424.SGD","LU2226246903.HKD","IE00BWXC8680.SGD","IE00BFSS7M15.SGD","LU0456842615.SGD","SNPE","SGXZ99366536.SGD","USXF","LU0203201768.USD","LU1267930227.SGD","NVDW","LU0823426308.USD","LU0080751232.USD","LU1645745479.HKD","LU0127658192.USD","TYLG","SG9999014880.SGD","BK4524","LU2097344431.USD","LU1691799644.USD","BK1191","LU2929501877.USD","LU2237438978.USD","LU0856984785.SGD","HK0000306701.USD","LU1242518857.USD","NVDX","SOXQ","LU1718418525.SGD","LU0949170772.SGD","LU0795875169.SGD","NVDB","NVDS","ALBmain","SG9999014898.SGD","LU0323239441.USD","BK4538","LU1282648689.USD","BK4535","LU0256863902.USD","CLIX","LU2860962120.EUR","LU0384037296.USD","LU1316542783.SGD","LU0795875086.SGD","LU0310800965.SGD","IE0004086264.USD","LU0138981039.USD","LU0210536198.USD","LU0234572021.USD","LU0354030438.USD","BK4579","LU0308772762.SGD","LU2237443382.USD","LU0724617625.USD","LU0175139822.USD","BK4141","SG9999014906.USD","BK1519","IE00BFSS8Q28.SGD","LU0630378692.HKD","IE00BMPRXR70.SGD","LU0553294199.USD","HK0000304797.USD","CLSE","IE0034224299.USD","LU2756315318.SGD","IE0034235303.USD","LU2168564222.USD","LU1935042488.USD","LU0868494708.USD","01316","SMHX","LU2087625088.SGD","SG9999015358.SGD","BK4567","LU2463028550.USD","LU0543330566.HKD","LU2931357623.SGD","LU0348735423.USD","LU2242649171.HKD","BK1518","LU0029864427.USD","LU0531971595.HKD","BK4558","LU0109391861.USD","LU0501845795.SGD","BK4551","LU2394011477.USD","NVDG","IE00B5TLWC47.USD","SG9999015341.SGD","IE00BZ1G4Q59.USD","IE00BD6J9T35.USD","LU2063271972.USD","LU0359201612.USD","06869","LU1232071149.USD","LU2462591350.SGD","IE0004445015.USD","LU2552382132.HKD","LU1803068979.SGD","SGXZ80539844.SGD","LU2047632596.USD","LU2237443895.HKD","LU1035775433.USD","TEK","LU1244550494.USD","MCHS","LU0069063385.USD","LU0348825331.USD","LU0143551892.USD","LU0274383008.USD","LU0762541174.USD","LU1699723380.USD","LU0912757837.SGD","LU1804176565.USD","LU0345769631.USD","LU0047713382.USD","LU2237443978.SGD","IE0034235295.USD","LU0456846285.SGD","LU0289961442.SGD","LU1989772840.SGD","BK1587","IE00B7KXQ091.USD","LU0198837287.USD","LU1551013425.SGD","LU2403377893.USD","07788","002703","LU1323610961.USD","IE0001KFT4U8.USD","LU2148611432.USD","LU2168564149.EUR","WXXWY","IE00BHPRN162.USD","LU0640476718.USD","VT","IE0009G5SDU7.USD","TTEQ","LU2294711713.HKD","NVDA","BK4548","LU1732800096.USD","LU1435385759.SGD","BK4549","LU0251132253.USD","LU0417516902.SGD","LU0354030511.USD","LU0187121727.USD","LU1935043536.SGD","IE0004091025.USD","LU0210528500.USD","LU0871576103.HKD","LU2089284900.SGD","LU2430703095.HKD","LU0174119429.USD","LU1861220033.SGD","LU0516423174.USD","LU2065171402.SGD","LU0181495838.USD","LU0821914370.USD","LU1821325948.USD","LU1633808545.USD","LU0889565833.HKD","LU2023250330.USD","HK0000914660.USD","LU1008478684.HKD","LU0211328371.USD","LU0823434740.USD","SG9999018857.SGD","LU2361044949.HKD","002821","DIPS","LU0149721374.USD","LU0348816934.USD","HK0000819398.USD","LU2108987350.USD","LU1935043023.USD","IE00B19Z8X17.USD","LU2125909247.SGD","LU0588546209.SGD","LU0557290698.USD","IE00B5949003.HKD","IE00BQXX3F31.USD","IE00BQXX3D17.EUR","LU0096362180.USD","LU1935042215.USD","LU2954938101.SGD","SG9999015945.SGD","LU2211815571.USD","LU0353189763.USD","09888","LU0048584097.USD","LU1429558221.USD","LU2491049909.HKD","LU1481107354.HKD","LU2328871848.SGD","ESLG","SG9999014567.USD","LU0957808578.USD","LU1880398554.USD","02268","IE00BJTD4V19.USD","LU1629891620.HKD","IE00BMPRXQ63.HKD","GAMR","LU1670756490.USD","LU1720050803.USD","LU0320765059.SGD","BK4554","LU1064131342.USD","BK1588","LU1282649067.USD","LU1732799900.SGD","LU1153585028.USD","LU2456880835.USD","LU2089985449.USD","SG9999002562.SGD","01888","LU2347655156.SGD","NVDY","LU0965509101.SGD","BBYY","BK4565","LU2286300806.USD","LU0053666078.USD","BK4605","TCHI","LU1280957306.USD","IE00B3S45H60.SGD","SG9999014914.USD","LU0820561818.USD","LU0511384066.AUD","LU2092627202.USD","09995","LU1127390331.HKD","LU2023251221.USD","LU2065169927.USD","FDTX","BABC","LU0345770993.USD","LU2462591277.SGD","01797","LU1046422090.SGD","LU0823414478.USD","LU0466842654.USD","LU0820561909.HKD","LU1400636574.HKD","IE000ITXATA3.USD","LU0823421416.USD","LU0965509283.SGD","LU2237957811.SGD","LU2168564495.EUR","LU0672654240.SGD","LU0094547139.USD","LU0417516738.SGD","LU0310800379.SGD","ARTY","HK0000532082.HKD","LU0348723411.USD","BK1149","SG9999004303.SGD","LU1105468828.SGD","LU1152091168.USD","LU0043850808.USD","LU2433249047.HKD","IE000W1ABFV2.USD","DRAG","BK1610","IE00BJTD4N35.SGD","LU1951198990.SGD","LU2111349929.HKD","LU0359202008.SGD","LU0197773673.USD","BK4502","BK1575","LU1769817179.HKD","KURE","SOXX","LU0072462426.USD","LU0762542818.HKD","LU1974910355.USD","LU2100268510.USD","LU1923622291.USD","EFIV","LU0211327993.USD","LU1066051225.USD","LU1983260115.SGD","BK4531","BK1141","KBAB","688428","LU2360032135.SGD","LU2089283258.USD","LU0158827781.USD","SNVD.UK","HK0000914686.HKD","LU0648948544.HKD","LU1496350171.SGD","SG9999014674.SGD","LU0307460666.USD","BK1228","TTXU","LU0140636845.USD","LU0965509010.AUD","LU2543165471.USD","BABO","LU2552382058.USD","LU1778281490.HKD","LU0516422440.USD","LU1823568750.SGD","LU0861579265.USD","CHAT","LU2322448791.USD","IE00BDCRKT87.USD","LU0266013472.USD","688331","IE00BKDWB100.SGD","LU2505996681.GBP","LU2602419157.SGD","LU0476273544.USD","LU0345769128.USD","BK4532","BK1144","LU0545039389.USD","BK1583","LU1868836757.USD","LU0516423091.SGD","LU1282649141.HKD","BK4122","LU0797268264.HKD","LU1046421795.USD","LU2458330169.SGD","ILDR","SNVDA2609","LU0788109477.HKD","LU0097036916.USD","LU0823414551.USD","LU1048588211.SGD","LU0310799852.SGD","LU1051768304.USD","LU0689626769.HKD","LU0738911758.USD","LU1366192091.USD","LU1244550577.SGD","LU2249611893.SGD","LU2271345857.HKD","LU0642271901.SGD","LU0133085943.USD","LU1934455863.HKD","LU2106854487.HKD","NVIW.SI","LU0039217434.USD","LU0880133367.SGD","NVD","LU0359201885.HKD","LU2326559502.SGD","IE00B19Z8W00.USD","LU0164880469.USD","LU0211977185.USD","LU0345768153.USD","LU2361045086.USD","LU0985320562.USD","LU2272731865.HKD","LU2357305700.SGD","JGRO","LU1145028129.USD","BK1109","LU0689472784.USD","IE0034235188.USD","07388","LU2247934214.USD","LU1242518931.SGD","02556","LFGY","LU1267930573.SGD","LU0234570918.USD","LU0762540952.USD","IE0009356076.USD","LU0274383776.USD","LU2417539215.USD","LU2413666699.HKD","BK4504","FTEC","IE00BJJMRX11.SGD","SOXY","LU2065170008.USD","NVC","LU1623119135.USD","LU1808992512.USD","SG9999002828.SGD","LU0029874061.USD","LU0128526141.USD","LU2077746001.SGD","LU2471134796.USD","IE00BFMHRM44.USD","LU0918141705.HKD","LU1037948541.HKD","LU0661504455.SGD","LU1152091754.HKD","IE0005OL40V9.USD","LU0708995401.HKD","ABFL","LU1116320901.HKD","LU1244550221.USD","LU0326950275.SGD","LU2360106780.USD","ROM","LU0170899867.USD","IE00BJJMRY28.SGD","LU1880383366.USD","LU0979878070.USD","LU2487616109.SGD","LU0957791311.USD","LU0106261372.USD","LU0124676726.USD","LU1328277881.USD","LU0057025933.USD","LU1674673428.USD","BABU","LU0516422366.SGD","LU1642822529.SGD","NVDL","LU0390134368.USD","LU1923622614.USD","SG9999015986.USD","LU0719512351.SGD","09969","LU1720051108.HKD","LU2125909916.SGD","LU2272731782.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171799602","title":"ETF Market Daily: Healthcare Sector Shows Solid Valuations While Innovative Drug Subsegments See Dense Catalysts, Spotlight on Hang Seng Biotech ETF and STAR Innovative Drug ETF","url":"https://stock-news.laohu8.com/highlight/detail?id=1171799602","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171799602?lang=en_us&edition=fundamental","pubTime":"2026-08-25 19:50","pubTimestamp":1787658655,"startTime":"0","endTime":"0","summary":"Today, China's three major A-share indices delivered mixed performances, with the Shanghai Composite Index edging up 0.19%, the Shenzhen Component Index slipping 0.35%, and the ChiNext Index falling...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159316","159982","159992","LNGR","159938","BK4585","FDN","159892","BK1574","BK4588","HBImain","09939","06978","BK1161","BK1515","BK4550","IBBQ","MEDX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":9,"totalSize":382,"code":"91000000","status":"200"}]}}